Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy

Lloyd Tanner, Gabriel T. Mashabela, Charles C. Omollo, Timothy J. de Wet, Christopher J. Parkinson, Digby F. Warner, Richard K. Haynes, Lubbe Wiesner

Microbiology Spectrum · 2021 · 10 citations · 90 references

DOIFull text

Open access

Concepts

Abstract

This study addresses the development of novel therapeutic compounds for the eventual treatment of drug-resistant tuberculosis. Tuberculosis continues to progress, with cases of Mycobacterium tuberculosis ( M. tuberculosis ) resistance to first-line medications increasing.

References

90